LIC held 8.08 percent stake in Indiabulls Housing Finance till December and sold 3.99 percent stake in the bourses today

Read More

​ LIC held 8.08 percent stake in Indiabulls Housing Finance till December and sold 3.99 percent stake in the bourses today LIC held 8.08 percent stake in Indiabulls Housing Finance till December and sold 3.99 percent stake in the bourses today  Moneycontrol Latest News Read More  

LIC held 8.08 percent stake in Indiabulls Housing Finance till December and sold 3.99 percent stake in the bourses today

According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones.

Read More

​ According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones. According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones.  Moneycontrol Latest News Read More  

According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones.

According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones.

Read More

​ According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones. According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones.  Moneycontrol Latest News Read More  

According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones.

Semgalutide has almost 66 percent of the market share in the anti-obesity segment.

Read More

​ Semgalutide has almost 66 percent of the market share in the anti-obesity segment. Semgalutide has almost 66 percent of the market share in the anti-obesity segment.  Moneycontrol Latest News Read More  

Semgalutide has almost 66 percent of the market share in the anti-obesity segment.

Sitharaman#39;s remarks comes months after the International Monetary Fund (IMF), while releasing a set of projections, flagged the possibility of India#39;s general government debt exceeding 100 percent of GDP

Read More

​ Sitharaman#39;s remarks comes months after the International Monetary Fund (IMF), while releasing a set of projections, flagged the possibility of India#39;s general government debt exceeding 100 percent of GDP Sitharaman#39;s remarks comes months after the International Monetary Fund (IMF), while releasing a set of projections, flagged the possibility of India#39;s general government debt exceeding 100 percent of GDP  Moneycontrol Latest News Read More  

Sitharaman#39;s remarks comes months after the International Monetary Fund (IMF), while releasing a set of projections, flagged the possibility of India#39;s general government debt exceeding 100 percent of GDP

Fortis had reported a net profit of Rs 142 crore in the same quarter of the previous year

Read More

​ Fortis had reported a net profit of Rs 142 crore in the same quarter of the previous year Fortis had reported a net profit of Rs 142 crore in the same quarter of the previous year  Moneycontrol Latest News Read More  

Fortis had reported a net profit of Rs 142 crore in the same quarter of the previous year

Motilal Oswal recommended Neutral rating on Relaxo Footwears with a target price of Rs 850 in its research report dated January 31, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Relaxo Footwears with a target price of Rs 850 in its research report dated January 31, 2024. Motilal Oswal recommended Neutral rating on Relaxo Footwears with a target price of Rs 850 in its research report dated January 31, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Relaxo Footwears with a target price of Rs 850 in its research report dated January 31, 2024.

Motilal Oswal recommended Neutral rating on Procter and Gamble Hygiene and Health Care with a target price of Rs 16,000 in its research report dated January 31, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Procter and Gamble Hygiene and Health Care with a target price of Rs 16,000 in its research report dated January 31, 2024. Motilal Oswal recommended Neutral rating on Procter and Gamble Hygiene and Health Care with a target price of Rs 16,000 in its research report dated January 31, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Procter and Gamble Hygiene and Health Care with a target price of Rs 16,000 in its research report dated January 31, 2024.

Motilal Oswal recommended Neutral rating on Shree Cement with a target price of Rs 27,700 in its research report dated January 31, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Shree Cement with a target price of Rs 27,700 in its research report dated January 31, 2024. Motilal Oswal recommended Neutral rating on Shree Cement with a target price of Rs 27,700 in its research report dated January 31, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Shree Cement with a target price of Rs 27,700 in its research report dated January 31, 2024.

Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 500 in its research report dated February 01, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 500 in its research report dated February 01, 2024. Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 500 in its research report dated February 01, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 500 in its research report dated February 01, 2024.